Observational Study
Copyright ©The Author(s) 2016.
World J Gastroenterol. Oct 21, 2016; 22(39): 8812-8819
Published online Oct 21, 2016. doi: 10.3748/wjg.v22.i39.8812
Table 1 Clinical analysis and anthropometry of the study population and the control group
Patients with NAFLD
Control group
MedianSD95%CIMedianSD95%CI
BMI28.714.0726.2-29.5823.753.521.86-25.84
ALP185104.54122.21-244.81219.0103.00136.13-303.8
ALT3152.2130-59.516.550.715-20.45
AST2525.7821.14-30.852225.2120-26
Bilirubin0.530.40740.38-0.680.590.210.37-0.67
γ-GT2112.2417.14-28.97119.9810-12
Insuline17.6111.4612.12-24.1411.63.48.17-12.34
Cholesterol15438.56130.44-168.55142.528.8136-167
Blood glucose857.0883.14-89.70833.681-84
Triglycerides7768.8668.68-114.6560.524.6450-84.45
VAT368.351258.23334.9-501.7275.976.02252.4-299.9
SAT1949.2211184.91743.6-2886.01352.9746.95840.3-1539.4